Literature DB >> 24365135

A beneficial effect of rituximab on autoimmune thrombotic thrombocytopenic purpura: just a B-cell depletion?

Jae Il Shin1, Michael Eisenhut2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24365135     DOI： 10.1016/j.jaci.2013.11.022

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN： 0091-6749            Impact factor:   10.793


× No keyword cloud information.
  3 in total

Review 1.  From autoinflammation to autoimmunity: old and recent findings.

Authors:  Francesco Caso; Luisa Costa; Valeria Nucera; Giuseppe Barilaro; Ignazio Francesco Masala; Rossella Talotta; Paolo Caso; Raffaele Scarpa; Piercarlo Sarzi-Puttini; Fabiola Atzeni
Journal:  Clin Rheumatol       Date:  2018-07-16       Impact factor: 2.980

2.  Long-lasting uveitis remission and hearing loss recovery after rituximab in Vogt-Koyanagi-Harada disease.

Authors:  Francesco Caso; Donato Rigante; Antonio Vitale; Luisa Costa; Vittoria Bascherini; Eugenia Latronico; Rossella Franceschini; Luca Cantarini
Journal:  Clin Rheumatol       Date:  2014-09-16       Impact factor: 2.980

Review 3.  Biological treatments in Behçet's disease: beyond anti-TNF therapy.

Authors:  Francesco Caso; Luisa Costa; Donato Rigante; Orso Maria Lucherini; Paolo Caso; Vittoria Bascherini; Bruno Frediani; Rolando Cimaz; Edoardo Marrani; Laura Nieves-Martín; Mariangela Atteno; Carmela G L Raffaele; Giusyda Tarantino; Mauro Galeazzi; Leonardo Punzi; Luca Cantarini
Journal:  Mediators Inflamm       Date:  2014-06-30       Impact factor: 4.711
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.